Moderna reported better-than-expected 1Q24 revenue of $167 million and its pipeline looks promising. Read my earnings ...
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
The US Food and Drug Administration (FDA) approved mRESVIA (mRNA-1345, Moderna), a vaccine for respiratory syncytial virus (RSV). The mRNA vaccine is approved for adults aged 60 years or ...
This article discusses Donald Trump convicted on 34 charges of falsifying business records, the upcoming PCE data, Boeing's ...
The US Food and Drug Administration (FDA) has approved the messenger RNA-based (mRNA) vaccine against respiratory syncytial virus (RSV) for people ages 60 and older. The vaccine, made by ...
Reports of a rare nervous system disorder are "more common than expected" in older U.S. adults who got the new RSV vaccines.